SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-037905
Filing Date
2023-11-08
Accepted
2023-11-08 16:54:02
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aadi-20230930.htm   iXBRL 10-Q 1768337
2 EX-31.1 aadi-20230930xex311.htm EX-31.1 10967
3 EX-31.2 aadi-20230930xex312.htm EX-31.2 10976
4 EX-32.1 aadi-20230930xex321.htm EX-32.1 5365
5 EX-32.2 aadi-20230930xex322.htm EX-32.2 5324
  Complete submission text file 0001628280-23-037905.txt   7292126

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20230930.xsd EX-101.SCH 46932
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aadi-20230930_cal.xml EX-101.CAL 61114
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20230930_def.xml EX-101.DEF 215497
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20230930_lab.xml EX-101.LAB 597585
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20230930_pre.xml EX-101.PRE 391134
65 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20230930_htm.xml XML 907285
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 231388962
SIC: 2834 Pharmaceutical Preparations